pk 11195 has been researched along with Bile Duct Cancer in 1 studies
PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Okaro, AC | 1 |
Fennell, DA | 1 |
Corbo, M | 1 |
Davidson, BR | 1 |
Cotter, FE | 1 |
1 other study available for pk 11195 and Bile Duct Cancer
Article | Year |
---|---|
Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-X(L) and Mcl-1 expressing human cholangiocarcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Chol | 2002 |